Clinical trial Recruiting at 1 site Interventional Ages 20 to 50

Rebuilding the gum papilla with three methods

Official title: Restoring Lost Pink Triangle by Comparing Three Different Papillary Reconstruction Modalities: A Randomized Clinical Trial

Run by Mansoura University · NCT07159802 · Data updated 2026-11-12

This study will try three ways—hyaluronic acid injections (with possible booster doses), slow-resorbing ALB-PRF injections, and a minimally invasive modified Beagle surgery—to restore lost interdental papilla in adults with class 1–2 papilla defects.

Quick facts

Study typeInterventional
Ages20 Years to 50 Years
SexAll
Enrollment24 (estimated)
SponsorMansoura University
Academic / other
Locations1 site (Al Mansurah, Dakahlia Governorate)
StatusRecruiting
StartedFebruary 25, 2025
Main results expectedApril 25, 2026
Study endsApril 30, 2026
Registry record updatedSeptember 8, 2025
Trial IDNCT07159802 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 20–50 with class 1 or 2 interdental papilla loss, a minimum of 3 mm attached gingiva, and stage 1–2 periodontitis who are non-smokers and can maintain oral hygiene are ideal candidates.

Probably not a fit

Patients with stage 3–4 periodontitis, smokers, those with chronic systemic diseases, high frenum attachment, diastema, pregnancy or lactation, or inadequate attached gingiva are unlikely to receive benefit from these procedures.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with class 1–2 interdental papilla loss will receive one of three reconstruction techniques at a single center: hyaluronic acid injections with booster doses as needed, autologous lyophilized platelet-rich fibrin (ALB-PRF) injections intended for a slower resorption and longer effect, or a minimally invasive surgical repair modified from Beagle's technique. Treatments will be performed according to a standardized protocol and patients will be followed to document papilla fill, aesthetic outcomes, and any complications. Eligible participants are adults 20–50 years old with at least 3 mm of attached gingiva and stage 1–2 periodontitis, while smokers and those with systemic disease or other exclusions are not eligible. The trial compares clinical durability and patient-reported aesthetic results across the three modalities at Mansoura University.

Why it matters

Potential benefit: If successful, one of these methods could offer a more reliable, longer-lasting, and less invasive way to rebuild the interdental papilla and improve smile appearance.

How similar studies have gone: Small clinical reports and case series have reported promising results for hyaluronic acid and PRF in soft-tissue papillary augmentation and mixed outcomes for surgical methods, but direct head-to-head comparisons of all three approaches are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. Age: 20 to 50 years. 2. Class 1 and 2 inter dental papilla loss according to Nordland \& Tarnow classification (17).

  3\. Adequate attached gingiva (minimum 3 mm). 4. Stage 1or 2 periodontitis (18).

Exclusion Criteria:

* 1\. Smokers. 2. Chronic systemic diseases. 3. Drug usage. 4. High frenum attachment. 5. Diastema. 6. Pregnancy and lactation. 7. Stage 3 \& 4 periodontitis (18). 8. Noncompliance with oral hygiene measures.

Where it's running

  • Mansoura University
    Al Mansurah, Dakahlia Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.